Sandu Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹38.50(0.79%)December 11, 2025 15:29:58 PM IST
- NSE
- BSE
- Vol : 1.68 K (NSE + BSE)Last 20 day avg : 1.82 K
Sandu Pharmaceuticals is trading 0.79% upper at Rs 38.50 as compared to its last closing price. Sandu Pharmaceuticals has been trading in the price range of 39.50 & 36.76. Sandu Pharmaceuticals has given -33.29% in this year & -3.32% in the last 5 days. Sandu Pharmaceuticals has TTM P/E ratio 27.86 as compared to the sector P/E of 49.45.The company posted a net profit of 0.52 Crores in its last quarter.Listed peers of Sandu Pharmaceuticals include Divi's Laboratories (2.22%), Dr Reddy's Laboratories (1.75%), Torrent Pharmaceuticals (0.26%).The Mutual Fund holding in Sandu Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sandu Pharmaceuticals was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 11, 2025, 10:12 PM UTC
- BetaLow volatility0.52Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.09Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.88The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values22.82Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-4.58The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,432.25 | 2.22 | 1,70,923.07 | 76.57 | 11.22 | 0.47 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,272.95 | 1.75 | 1,06,357.15 | 18.64 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 3,802.90 | 0.26 | 1,28,663.23 | 66.02 | 16.76 | 0.85 | 17.62 |
| Cipla | Moderately Bearish | 1,512.00 | 1.53 | 1,22,135.01 | 22.97 | 3.88 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Bullish | 1,806.90 | 1.16 | 4,32,750.00 | 37.48 | 5.97 | 0.89 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE751D01014
- BSE Code524703
- NSE Code
Sandu Pharmaceuticals is trading at 38.50 as on Thu Dec 11 2025 09:59:58. This is 0.79% upper as compared to its previous closing price of 38.20.
The market capitalization of Sandu Pharmaceuticals is 37.19 Cr as on Thu Dec 11 2025 09:59:58.
The 52 wk high for Sandu Pharmaceuticals is 62.80 whereas the 52 wk low is 37.00
Sandu Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 27.86
- Sector P/E: 49.45
- Dividend Yield: 2.09%
- D/E ratio: 0.01
Sandu Pharmaceuticals reported a net profit of 1.55 Cr in 2025.
EQUITY QUICK LINKS
Sandu Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.